🔎 Trials Near Me

홈 › 자궁내막암 › 버지니아

버지니아의 자궁내막암 임상 시험

자궁내막암 관련 연구 52개가 버지니아 내 여러 지역에서 참여자를 모집하고 있습니다.

버지니아의 도시

공식 연구 텍스트(영어)

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors

  • Site 04, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07814248

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

  • University of Virginia Cancer Center, Charlottesville
  • VCU Massey Comprehensive Cancer Center, Richmond
피험자 모집 중3상
18세 이상 · 여성 · 2026. 9. 30. 업데이트됨 · NCT07198074

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

  • University of Virginia Cancer Center, Charlottesville
  • VCU Massey Cancer Center at Stony Point, Richmond
  • VCU Massey Comprehensive Cancer Center, Richmond
  • 외 1개
피험자 모집 중3상
18세 이상 · 여성 · 2026. 9. 29. 업데이트됨 · NCT05256225

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

  • Virginia Commonwealth University/ Massey Cancer Center, Richmond
피험자 모집 중관찰 연구
18세 이상 · 여성 · 2026. 9. 29. 업데이트됨 · NCT05051722

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Ballad Health Cancer Care - Bristol, Bristol
  • University of Virginia Cancer Center, Charlottesville
  • Inova Schar Cancer Institute, Fairfax
  • 외 5개
피험자 모집 중2상
전 연령 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05564377

Study of AVZO-021 in Patients With Advanced Solid Tumors

  • Avenzo Therapeutics Recruiting Site, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05867251

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  • University of Virginia, Charlottesville
  • NEXT Virginia, Fairfax
피험자 모집 중1상
19세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06586957

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

  • University of Virginia Cancer Center, Charlottesville
피험자 모집 중2상
18세 이상 · 여성 · 2026. 9. 28. 업데이트됨 · NCT05112601

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

  • Virginia Commonwealth University, Richmond
피험자 모집 중1/2상
18세 이상 · 여성 · 2026. 9. 25. 업데이트됨 · NCT03564340

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

  • University of Virginia Cancer Center, Charlottesville
  • Virginia Commonwealth University, Richmond
피험자 모집 중2상
18세 이상 · 여성 · 2026. 9. 24. 업데이트됨 · NCT05640999

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • NEXT Oncology Virginia, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06128551

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Virginia Cancer Specialists, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT05983432

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

  • Inova Schar Cancer Institute ( Site 6003), Fairfax
  • Virginia Cancer Specialists (VCS) ( Site 8008), Fairfax
  • VCU Health Adult Outpatient Pavillion ( Site 5000), Richmond
피험자 모집 중3상
18세 이상 · 여성 · 2026. 9. 17. 업데이트됨 · NCT06952504

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • NEXT Oncology, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07109726

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Virginia Cancer Specialists, Fairfax
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT04585750

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • Virginia Cancer Specialists, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT06293898

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

  • University of Virginia, Charlottesville
피험자 모집 중3상
18세 이상 · 여성 · 2026. 9. 9. 업데이트됨 · NCT07166094

Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

  • NEXT Oncology, Fairfax
피험자 모집 중1상
18세 이상 · 여성 · 2026. 9. 3. 업데이트됨 · NCT07755436

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

  • Research Site, Charlottesville
  • Research Site, Fairfax
피험자 모집 중3상
18세 이상 · 여성 · 2026. 9. 3. 업데이트됨 · NCT06989112

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

  • NEXT Virginia, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 27. 업데이트됨 · NCT07227168

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

  • NEXT Virginia, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT07383506

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

  • University of Virginia, Charlottesville
피험자 모집 중1상
15세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT06276491

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

  • Inova Schar Cancer Institute, Falls Church
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT06774963

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

  • University of Virginia Health System, Charlottesville
피험자 모집 중2상
18세 이상 · 여성 · 2026. 8. 21. 업데이트됨 · NCT05548296

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

  • Research Site, Fairfax
피험자 모집 중1/2상
18세 ~ 130세 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT05797168

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

  • University of Virginia Health System, Charlottesville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT04104776

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

  • Normunity Investigational Site, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT07182149

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • University of Virginia, Charlottesville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT05919264

A Study of PHST001 in Advanced Solid Tumors

  • NEXT Oncology - Virginia, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 12. 업데이트됨 · NCT06840886

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

  • NEXT Oncology - Virginia Cancer Specialists, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT07444814

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • Virginia Cancer Specialists, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT06330064

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • USOR Virginia Cancer Specialists, Fairfax
  • USOR Virginia Oncology Associates, Norfolk
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 4. 업데이트됨 · NCT05579366

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • NEXT Virginia, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT06270706

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • Virginia Cancer Specialists, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 30. 업데이트됨 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  • Research Site, Fairfax
  • Research Site, Falls Church
  • Research Site, Norfolk
  • 외 2개
피험자 모집 중3상
18세 이상 · 여성 · 2026. 7. 29. 업데이트됨 · NCT07044336

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

  • NEXT Virginia, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT07524322

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

  • NEXT Virginia, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT05208762

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

  • 522, Fairfax
  • 300, Norfolk
피험자 모집 중2상
18세 이상 · 여성 · 2026. 7. 16. 업데이트됨 · NCT06906341

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • USO-Virginia Cancer Specialists, PC, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 7. 업데이트됨 · NCT05768139

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

  • NEXT Oncology Virginia, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT05377996

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.